Macrophage-targeted immunocytokine leverages myeloid, T, and NK cell synergy for cancer immunotherapy
{{output}}
Tumor-associated macrophages (TAMs) expressing the myeloid checkpoint TREM2 are key immunosuppressive cells in the tumor microenvironment (TME), driving tumor progression and contributing to poor prognosis in cancer patients. Due to their pivotal role, TAMs ha... ...
